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Figure 2. GM 6001 increases meniscal shear strength in the presence
of IL-1. The interfacial shear strength of repair was measured after treat-
ment of meniscal repair model explants with control media, 100 pg/mL
IL-1, 100 pg/mL IL-1 and 200 ng/mL GM 6001, and 100 pg/mL IL-1 and
200 ng/mL GM 6001 negative control (NC GM 6001) for 14 days (n = 9−11
explants per treatment group). The bar indicate the mean shear strength
in kPa + standard error. a: p< 0.0005 compared to control. b: p< 0.05
compared to IL-1 + GM 6001.
Results: Over time in culture there was a slight increase in MMP activity
in control explants, while Il-1 treatment progressively increased MMP
activity (Figure 1). On the other hand, in the presence of Il-1, the broad
spectrum MMP inhibitor GM 6001 signiﬁcantly suppressed MMP activity
in the media (p< 0.005). MMP activity was also reduced in the presence of
Il-1 by the MMP-3 and MMP-8 inhibitors (p< 0.05). Treatment of meniscal
repair model explants with Il-1 signiﬁcantly decreased the shear strength
of repair, as compared to control explants (Figure 2, p< 0.0005). In the
presence of Il-1, GM 6001 increased the shear strength of repair 2.3-
fold over Il-1 treated explants alone (p< 0.05). However, individual MMP
inhibitors did not alter the shear strength of repair in either the presence
or absence of Il-1.
Conclusions: We found that MMPs are responsible for approximately
50% of the Il-1 mediated inhibition of meniscal healing, as shown by
broad-spectrum inhibition of MMP activity. These results suggest that Il-1
may inhibit meniscal repair through the upregulation of MMPs, but the
inhibition of multiple MMPs is necessary to promote integrative meniscal
repair in vitro and potentially in vivo following joint injury or during arthritis.
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Purpose: To investigate morphometric change of cartilage in cMF and
TrF over the ﬁrst two years after acute ACL injury.
Methods: In this longitudinal MRI analysis we assessed a consecu-
tive sub-set of subjects included in an RCT of surgical versus non-
surgical treatment after acute ACL injury (The KANON study). 29 patients
(29 knees, 21 males) with a not more than 4 weeks old ACL rupture
were assessed by MRI and underwent similar extensive rehabilitation. 19
of these subjects (mean age 28, 95%CI, 26−30 y) in addition underwent
an ACL reconstruction within 7w from injury, while 10 (mean age 25,
95%CI 21−29 y) were treated with rehabilitation alone. MRI scans were
performed using a 1.5 T imager with a circular polarized surface coil at
baseline, 3 and 24 months after injury. A quantitative analysis was per-
formed where a multi-spectral image data set was created and computer
analyzed. To avoid artefact bias (i.e. ﬁxation material in group treated with
ACL reconstruction), change was measured from 3 to 24 months. We
quantiﬁed cartilage volume (VC), thickness (ThCcAB) and surface area
(AC) in cMF and TrF. Change was reported as mean change, percent
change and standard response mean (SRM, mean change divided by
the standard deviation of change).
Results: In cMF, cartilage morphometry measures increased from
3−24 months after injury (0.052<SRM>0.750). Mean cartilage thickness
and volume increased with 4.2% (95%CI, 2.1−6.3) and 4.5% (1.8−7.2)
respectively. Thickness increased more in knees treated with ACL recon-
struction than in knees treated with rehabilitation alone, 5.6% (2.8−8.4)
and 1.6% (−1.3−4.4), respectively. In TrF, mean measures decreased
(−0.430<SRM>−0.133). AC of TrF decreased (2.7%, 1.2−4.2) in knees
treated with ACL reconstruction but increased (1.2%, −0.4−2.7) in those
treated with rehabilitation alone (Table 1).
Conclusions: Cartilage hypertrophy of cMF, indicated by increased ThC-
cAB and VC, occurs during the ﬁrst 24 months after ACL injury. An early
ACL reconstruction appears to be associated with morphometric change
of cartilage in cMF and TrF after 2 years, where SRMs close to 1 were
observed.
Table 1: Mean change of cartilage surface area (AC), thickness (ThCcAB) and volume (VC)
between 3 and 24 months
All subjects (N=29) Rehab alone (n = 10) ACL reconstruction (n = 19)
Change mean
(95%CI)
Change %
mean
(95%CI)
SRM Change mean
(95%CI)
SRM Change mean
(95%CI)
SRM
AC (mm2)
cMF 1.8
(−11.5, 15.0)
0.4
(−1.1, 1.8)
0.052 −3.7
(−26.9, 19.6)
−0.114 4.6
(−13.0, 22.2)
0.126
TrF −32.0
(−60.3, −3.7)
−1.4
(−2.6, −0.1)
−0.430 24.0
(−6.4, 54.3)
0.566 −61.4
(−95.6, −27.1)
−0.864
ThCcAB (mm)
cMF 0.09
(0.04, 0.14)
4.2
(2.1, 6.3)
0.750 0.03
(−0.03, 0.1)
0.333 0.12
(0.06, 0.18)
0.923
TrF −0.02
(−0.08, 0.04)
−0.5
(−2.9, 1.8)
−0.133 0.02
(−0.02, 0.07)
0.286 −0.04
(−0.13, 0.04)
−0.235
VC (mm3)
cMF 65.4
(17.8, 113.0)
4.5
(1.8, 7.2)
0.522 16.0
(−39.0, 71.1)
0.208 91.4
(24.3, 158.4)
0.657
TrF −88.5
(−215.0, 37.9)
−1.2
(−3.9, 1.5)
−0.267 71.1
(−27.3, 169.5)
0.517 −172.6
(−353.4, 8.3)
−0.460
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Purpose: Although hypertrophic differentiation of chondrocytes is a cru-
cial step not only for physiological skeletal growth but also for pathological
disorders like osteoarthritis, the underlying molecular mechanism remains
unclear. This study investigated the role of CCAAT/enhancer-binding
protein b (C/EBPb), a multi-functional transcription factor, in chondrocytes
during endochondral ossiﬁcation.
Methods: To clarify the physiological function of C/EBPb, we initially
compared the skeletal phenotypes of homozygous C/EBPb-deﬁcient
(C/EBPb−/−) mice with those of the wild-type littermates (E16.5) by
Alizarin red, Alcian blue, von Kossa stainings, as well as type X collagen
(COL10) immunostaining and BrdU labeling. We further compared the
proliferation and hypertrophic differentiation in cultures of primary chon-
drocytes derived from ribs of the two genotype littemates by XTT assay,
real-time RT-PCR for COL10, MMP-13, VEGF, and ALP and Alizarin red
stainings. We also compared the same parameters between cultured
wild-type rib chondrocytes with retroviral overexpression of C/EBPb and
the control empty vector. The effect of the C/EBPb overexpression on
cell cycle was examined by a DNA histogram using a ﬂow cytometric
analysis. Identiﬁcation of transcriptional targets of C/EBPb was performed
by a microarray analysis, and was conﬁrmed by real-time RT-PCR. In
vivo expressions of C/EBPb and the target factor were examined by
immunohistochemistry in the mouse growth plates. Transcriptional activity
was examined using HuH-7 cells transfected with a luciferase-reporter
gene construct containing a 1 kb fragment of the promoter. The speciﬁc
binding of the identiﬁed region was veriﬁed by electrophoretic mobility shift
assay (EMSA). Functional relevance was examined by gene silencing by
the small interfering RNA (siRNA).
Results: The C/EBPb−/− mice exhibited dwarﬁsm with an elongated
proliferative zone and delayed chondrocyte hypertrophy in the growth
plate cartilage. The loss- and gain-of-functions of C/EBPb in cultured
chondrocytes revealed that C/EBPb was essential for suppression of
cell proliferation and promotion of hypertrophic differentiation, probably
by accelerating the exit from the cell cycle. The C/EBPb overexpression
caused accumulation of cells in the G0/G1 fraction, and a microarray
analysis identiﬁed several cell cycle factors as the transcriptional targets.
Among them, p57Kip2, a cyclin-dependent kinase inhibitor, was most
strongly up-regulated by the C/EBPb overexpression and down-regulated
